FDA recall D-0492-2017

Product

Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV

Reason for recall

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle

Distribution

Nationwide

Key facts

Status

Terminated

Initiation date

2017-01-19

Report date

2017-03-15

Termination date

2017-07-12

Voluntary/Mandated

Voluntary: Firm initiated

Location

Morgantown, WV, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0492-2017